Investment Rating - The report maintains a "Buy" rating for the company [3][7] Core Views - The company's 2025 performance aligns with expectations, with a revenue of 35.79 billion and a net profit of 3.89 billion, reflecting a year-over-year change of -5.2% and +0.67% respectively [2][3] - The financing leasing business shows growth, while the industrial operations revenue is stabilizing [7] - The company has a high dividend yield of 7.4%, with a total dividend of 0.56 HKD per share for the year [2][3] Financial Data and Profit Forecast - Revenue and net profit projections for 2024 to 2028 indicate a recovery trend, with expected net profits of 4.21 billion in 2026, 4.73 billion in 2027, and 5.22 billion in 2028, reflecting year-over-year growth rates of +8%, +13%, and +10% respectively [3][8] - The company’s return on equity (ROE) is projected to improve from 7.7% in 2025 to 9.2% by 2028 [3][8] - The dividend payout ratio is expected to remain stable, with a projected dividend per share (DPS) increase [7][8] Revenue and Profit Breakdown - The financing leasing segment generated 22.7 billion in revenue, a year-over-year increase of 4.5%, accounting for 63% of total revenue [7] - The industrial operations revenue decreased to 9.36 billion, down 19% year-over-year, contributing 26% to total revenue [7] - The health segment reported a revenue of 3.57 billion, down 13% year-over-year, making up 10% of total revenue [7] Investment Analysis - The report suggests a cautious adjustment of profit forecasts for 2026-2027 due to the contraction in domestic business, while maintaining a positive outlook on the international business growth [7] - The company is expected to see significant growth in overseas revenue, projected to increase by 50% in 2026 [7]
远东宏信（03360）：融资租赁支撑业绩正增，宏信建发收入筑底